Breidbart, E, Gallagher, M.P

KEY POINTS

  • The coronavirus disease 2019 (COVID-19) pandemic permanently transformed clinical care models for people living with type 1 diabetes, primarily by accelerating the use of telemedicine.
  • Remote patient monitoring and virtual health care allowed people with diabetes to maintain contact with health care providers without traveling to the office.
  • Diabetes technology was associated with improved health outcomes in people with type 1 diabetes during the pandemic.
  • Pre-existing health care disparities, including differences in diabetes technology use and access to telemedicine, persisted during the COVID-19 pandemic and were associated with worse health outcomes.
  •  Health care systems must work to create more flexible and equitable health care delivery models, to prepare for future pandemics and environmental disasters.
  • While there is no strong evidence directly linking severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection with type 1 diabetes pathogenesis, pandemic associated behaviors may have contributed to changes in the patterns of type 1 diabetes
    diagnosis.

Click here to view the article!

If you are a member of the T1DX-QI, you can view the full pdf in the portal.